Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-...( FREMONT Calif. Feb. 25 /- WaferGen Bi...)

FREMONT, Calif., Feb. 25 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced positive data on the company's SmartChip(TM) Real-Time PCR System. These validation results were presented today by WaferGen scientists and collaborative researchers from the University of Pittsburgh School of Medicine as part of a poster presentation at Cambridge Healthcare Institute's 16th International Molecular Medicine Tri-Conference. The conference is being held February 25-27 in San Francisco.

Key findings presented included:

• SmartChip system's ability to generate real-time polymerase chain reaction (PCR) results in clinical samples for approximately 1,000 oncology genes in triplicate on a single chip, using small amounts of RNA (300-500ngs) in less than three hours. We believe this demonstrates the SmartChip system's ability to produce the industry's fastest time to results.
• Significant reduction in required reaction volume from 25-50uL to 100nl, saving significantly on reagent cost.
• Establishment of the SmartChip system's equivalence in performance to current real-time PCR standards.
• Successful demonstration of key SmartChip system workflow elements, including primer-ready SmartChips and the drying and reconstitution of primers for rapid high-throughput 100 nL real-time PCR.

It is important to note that all of these results were achieved using clinical biological samples from emphysema, idiopathic pulmonary fibrosis (IPF) and healthy patients.

"The demonstration of the SmartChip system's ability to generate PCR results on a very large number of genes using only a small quantity of RNA in a significantly reduced timeframe has generated consid
'/>"/>